<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02079597</url>
  </required_header>
  <id_info>
    <org_study_id>NINJ1-001</org_study_id>
    <nct_id>NCT02079597</nct_id>
  </id_info>
  <brief_title>The Role of Ninjurin-1 During Systemic Inflammation</brief_title>
  <acronym>Ninj1</acronym>
  <official_title>Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Patrick Meybohm, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  With the underlying study the investigators address the question if Ninjurin-1 (Ninj1)
           expression is altered in patients with systemic inflammatory response syndrome (SIRS) in
           comparison to healthy volunteers.

        -  The adhesion molecule Ninj1 is induced following nerve injury where it contributes to
           nerve generation. Besides it is described to facilitate leukocyte migration especially
           in the nervous system.

        -  The investigators hypothesize that Ninj1 expression is increased in SIRS patients, which
           will fortify its impact during inflammation and the transferability from bench to
           bedside.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ninj1 expression on blood leukocytes</measure>
    <time_frame>one day post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>grade of systemic inflammation</measure>
    <time_frame>one day post surgery</time_frame>
    <description>routine inflammatory markers will be used to evaluate the grade of inflammation e.g. procalcitonin (PCT) Interleukin 6, lipopolysaccharide (LPS) binding protein (LBP). Retrospective evaluation for sepsis (bacterial infection)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Soluble Ninj1 concentration/expression rates</measure>
    <time_frame>one day post surgery</time_frame>
    <description>Concentration will be measured in plasma samples as well as from whole blood culture incubated with 100 ng/ml lipopolysaccharide for 6, 16 and 24 h.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Ninj1 Expression</condition>
  <condition>SIRS</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy individuals no infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIRS</arm_group_label>
    <description>SIRS patients no included in an interventional study no peroperative infection</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, plasma, RNA and cDNA extracted from whole blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        SIRS patients: Intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  cardiac surgery patients

        Exclusion Criteria:

          -  included in an interventional study

          -  Preoperative Infection (e.g. Endocarditis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Meybohm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, University Hospital Frankfurt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2014</study_first_submitted>
  <study_first_submitted_qc>March 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2014</study_first_posted>
  <last_update_submitted>September 1, 2014</last_update_submitted>
  <last_update_submitted_qc>September 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Patrick Meybohm, M.D.</investigator_full_name>
    <investigator_title>PD Dr. Patrick Meybohm, M.D.</investigator_title>
  </responsible_party>
  <keyword>SIRS</keyword>
  <keyword>Ninj1</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Healthy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

